Gland Pharma Limited (NSE:GLAND)
India
· Delayed Price · Currency is INR 1,781.40
-10.90 (-0.61%)
Jun 27, 2025, 3:30 PM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 293.50 billion as of June 27, 2025. Its market cap has decreased by -5.61% in one year.
Market Cap
293.50B
Enterprise Value
266.14B
Revenue
56.17B
Ranking
n/a
PE Ratio
42.01
Stock Price
1,781.40
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 293.50B, a decrease of -1.21%. That is a compound annual growth rate of -0.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 293.50B | 0.12% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | 382.04B | 28.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,005.93B |
| Divi's Laboratories | 1,748.51B |
| Cipla | 1,213.50B |
| Apollo Hospitals Enterprise | 1,007.36B |
| Zydus Lifesciences | 970.56B |
| Mankind Pharma | 952.91B |
| Aurobindo Pharma | 650.61B |
| Fortis Healthcare | 588.72B |